Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas

European Journal of Medicinal Chemistry
2009.0

Abstract

A three-dimensional (3D) quantitative pharmacophore model was developed from a training set of structurally diverse substituted ureas against Raf-1 kinase, which was well validated to be highly predictive by two methods, namely, test set prediction and Cat-Scramble method. Then a virtual database searching was performed with the pharmacophore model as a 3D query, and the bioactivities of the retrieved hits were predicted by the pharmacophore. Subsequently, molecular docking was carried out on the selected hits whose estimated IC(50) was less than 1 microM. Finally, 29 hits were identified as potential leads against Raf-1 kinase, which exhibited good estimated activities, high docking scores, similar binding mode to experimentally proven compounds and favorable drug-like properties. The study may facilitate the discovery and rational design of novel leads with potent inhibitory activity targeting Raf-1 kinase.

Knowledge Graph

Similar Paper

Virtual screening for Raf-1 kinase inhibitors based on pharmacophore model of substituted ureas
European Journal of Medicinal Chemistry 2009.0
Pharmacophore identification of Raf-1 kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Pharmacophore modeling and in silico screening for new KDR kinase inhibitors
Bioorganic & Medicinal Chemistry Letters 2007.0
Discovery of potential ZAP-70 kinase inhibitors: Pharmacophore design, database screening and docking studies
European Journal of Medicinal Chemistry 2009.0
Pharmacophore modeling and virtual screening for designing potential PLK1 inhibitors
Bioorganic & Medicinal Chemistry Letters 2008.0
Pharmacophore modeling study based on known Spleen tyrosine kinase inhibitors together with virtual screening for identifying novel inhibitors
Bioorganic & Medicinal Chemistry Letters 2009.0
3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors
European Journal of Medicinal Chemistry 2010.0
Pharmacophore modeling and virtual screening for the discovery of new transforming growth factor-β type I receptor (ALK5) inhibitors
European Journal of Medicinal Chemistry 2009.0
Discovery of novel CDK1 inhibitors by combining pharmacophore modeling, QSAR analysis and in silico screening followed by in vitro bioassay
European Journal of Medicinal Chemistry 2010.0
Three-Dimensional Quantitative Structure−Activity Relationship Analysis of a Set ofPlasmodium falciparumDihydrofolate Reductase Inhibitors Using a Pharmacophore Generation Approach
Journal of Medicinal Chemistry 2004.0